The von Hippel-Lindau (VHL) germline mutation V84L manifests as early-onset bilateral pheochromocytoma

American Journal of Medical Genetics. Part a
Mary-Alice AbbottRobert M Greenstein

Abstract

Von Hippel-Lindau (VHL) disease is a heritable tumor susceptibility syndrome caused by germline mutations in the VHL gene. The types of tumor that can occur in affected individuals include retinal and central nervous system hemangioblastoma, renal cell carcinoma, pheochromocytoma, and others. The pattern of tumor types that develops in a VHL-affected family defines the clinical subtype (1, 2A, 2B, 2C). Generally, it is difficult to accurately predict an individual's clinical phenotype based on their VHL mutation. However, in a few specific VHL mutations, a strong genotype-phenotype correlation has been established. We report here on the clinical findings in individuals from three unrelated families with a V84L VHL germline mutation, and present follow-up information regarding the only other reported family with this missense mutation. In each of these four families, the major clinical manifestation of VHL disease is multiple early-onset pheochromocytomas (VHL type 2C). This series of eight patients strengthens the correlation between the V84L mutation and the VHL type 2C phenotype, and improves our ability to provide prognostic and management recommendations for similarly affected individuals.

References

Aug 1, 1995·Nature Medicine·O IliopoulosW G Kaelin
Nov 1, 1995·Journal of Medical Genetics·P A CrosseyE R Maher
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·A PauseR D Klausner
Jul 1, 1997·Human Molecular Genetics·E R WoodwardE R Maher
Feb 28, 2001·Journal of Pediatric Surgery·A O CiftciN Büyükpamukçu
May 10, 2002·The New England Journal of Medicine·Hartmut P H NeumannUNKNOWN Freiburg-Warsaw-Columbus Pheochromocytoma Study Group
Aug 21, 2003·Journal of the National Cancer Institute·Jennifer BryantKatherine L Nathanson
Mar 1, 1953·The American Journal of Medicine·A S GLUSHIEND S LITTMAN
Apr 1, 1964·The American Journal of Medicine·K L MELMON, S W ROSEN
Feb 28, 2004·Expert Reviews in Molecular Medicine·F M Richards

❮ Previous
Next ❯

Citations

Oct 7, 2008·Mammalian Genome : Official Journal of the International Mammalian Genome Society·R RajasekaranRao Sethumadhavan
Feb 21, 2009·The Journal of Biological Chemistry·Katja KnauthAlexander Buchberger
Apr 6, 2011·Annals of Human Genetics·Emanuela LeonardiAlessandra Murgia
Nov 18, 2006·Journal of the American Academy of Dermatology·Warren R Heymann
Oct 18, 2013·Endocrine-related Cancer·Roeliene C KruizingaThera P Links
Sep 19, 2019·Journal of the Endocrine Society·Gustavo F C FagundesMadson Q Almeida

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.